Abstract
The invention relates to integrin binding peptides, pharmaceutical compositions comprising the peptides and to uses thereof as therapeutic, diagnostic, imaging and targeting agents.
| Original language | English |
|---|---|
| Patent number | IL258863 |
| Priority date | 21/10/16 |
| Publication status | Published - 28 Jun 2018 |